🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

I am honored and proud to serve as incoming president of GUPS and look forward to working alongside our skilled and dedicated members to advance the field of urologic pathology in keeping with the organization’s mission, vision and values.

Young female patient with enlarged thyroid lobes, Bethesda II. Thyroidectomy performed due to discomfort. Multiple adenomatoid nodules observed, some showing striking lipomatous metaplasia. Short thread, promise!

Dr. Petur Nielsen on cartilage tumors. 🔬Synovial chondromatosis "If you think of making the diagnosis of synovial chondrosarcoma, go outside, lay down, and let the thought pass". #BSTPath #PathTwitter #HMAR_BASTPC25

After an extraordinary year as co-Australian of the Year 2024 alongside his colleague and friend Professor Georgina Long AO, it was an honour to welcome RCPA Fellow Professor Richard Scolyer AO and guests to RCPA HQ this week to celebrate his remarkable contributions to science and medicine.

Early this week, I had a delightful opportunity to catch up with many of my wonderful friends and colleagues at the Royal College of Pathologists of Australasia in Sydney. We discussed many topics including the important role pathologists play that helps ensure people get the

Newly arrived ENDO WHO Blue Book Fun fact: Cover of all blue books show 3 entities with same entity shown 3 ways down each column Column1: Insulinoma (gross,H&E,insulin IHC) Column2:Gonadotroph PitNET (MRI,H&E,GATA3 IHC) Column3:SDH deficiency (the complex, SDHdefRCC, SDHB IHC)

Time to retire the “hybrid oncocytoma-chromophobe tumor” terminology? International Society of Urological Pathology, GU Pathology Society (GUPS) kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…

I am incredibly proud of my contributions to the World Health Organisation (WHO) over more than 20 years! Whilst in 2004, I was thrilled to be able to share our knowledge of a rare subtype of melanoma (that is now treated differently), as a chapter writer (3rd edition), my

Tumour in lung. Odd looking tumour present in vessels and lymph nodes. The IHC is definitive but stains a bit weaker in the tumour in vessels than in the lymph node. But what is the IHC marker and therefore what is the tumour?

In nature from Stanford Medicine by Max Diehn, MD/PhD & Ash Alizadeh, MD/PhD 🇺🇸 An ultrasensitive method for detection of cell-free RNA nature.com/articles/s4158… RARE-seq has a limit of detection of 0.05%, identifies ~30% of stage 1 lung cancers, and provides information on resistance mechanisms.

The IHC is both nuclear and cytoplasmic. It is CAMTA1. The tumours is also positive for endothelial markers and cytokeratins - therefore it is EPITHELIOID HAEMANGIOENDOTHELIOMA

Epithelioid Angiosarcoma

Hello, I'm reaching out to the #PathTwitter community to connect with Spanish pathology interns. I'd love to ask a few questions about your practice. Please feel free to contact me privately. Thanks!

Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning

🚨 ASCO #ASCO25 was absolutely incredible! 🧬✨ So many groundbreaking advances in oncology and exciting publications that are going to change patient care. 👉Sharing the key ones below The Lancet The Lancet Oncology Journal of Clinical Oncology JAMA JAMA Oncology Cancer Discovery - Also added the

Today I completed my 250th Parkrun down at the Greenway. I feel so touched at how many people showed up to demonstrate their support and kindness. Parkrun is such an important staple in my week and a fantastic, volunteer-run organisation who make it easy and accessible for anyone

One of the true greats of pathology . . . a great painting that captures the essence of the man